|本期目录/Table of Contents|

[1]高嘉营,金发光.肺癌自身抗体在肺癌诊断中的研究进展[J].中华肺部疾病杂志,2023,(05):739-741.[doi:10.3877/cma.j.issn.1674-6902.2023.05.038]
点击复制

肺癌自身抗体在肺癌诊断中的研究进展(PDF)

《中华肺部疾病杂志》[ISSN:1006-6977/CN:61-1281/TN]

卷:
期数:
2023年05期
页码:
739-741
栏目:
综述
出版日期:
2023-10-20

文章信息/Info

Title:
-
作者:
高嘉营; 金发光
710038 西安, 空军军医大学第二附属医院呼吸与危重症医学科
Author(s):
-
关键词:
支气管肺癌;  自身抗体;  早期诊断;  预后
Keywords:
-
分类号:
R734.2
DOI:
10.3877/cma.j.issn.1674-6902.2023.05.038
摘要:
-
Abstract:
-

参考文献/References:

1 中国临床肿瘤学会血管靶向治疗专家委员会,中国临床肿瘤学会非小细胞肺癌专家委员会,中国临床肿瘤学会非小细胞肺癌抗血管生成药物治疗专家组.晚期非小细胞肺癌抗血管生成药物治疗中国专家共识(2020版)[J]. 中华肿瘤杂志, 2020, 42(12): 1063-1077.
2 Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249.
3 Henschke CI, Yankelevitz DF, Libby DM, et al. Survival of patients with stage I lung cancer detected on CT screening[J]. N Engl J Med, 2006, 355: 1763-1771.
4 Miller KD, Nogueira L, Mariotto AB, et al. Cancer treatment and survivorship statistics, 2019[J]. CA Cancer J Clin, 2019, 69(5): 363-385.
5 Bach PB, Mirkin JN, Oliver TK, et al. Benefits and harms of CT screening for lung cancer: a systematic review[J]. JAMA, 2012, 307: 2418-2429.
6 Walter JE, Heuvelmans MA, Oudkerk M, et al. Small pulmonary nodules in baseline and incidence screening rounds of low-dose CT lung cancer screening[J]. Transl Lung Cancer Res, 2017, 6(1): 42-51.
7 Oudkerk M, Liu S, Heuvelmans MA, et al. Lung cancer LDCT screening andmortality reduction-evidence, pitfalls and future perspectives [J]. Nat Rev ClinOncol, 2021, 18(3): 135-151.
8 朱梦婵, 邰先桃, 王 坚, 等. 外泌体及外泌体微小RNA在肺动脉高压中的作用与机制[J/CD]. 中华肺部疾病杂志(电子版), 2019, 12(6): 776-779.
9 Sozzi G, Boeri M, Rossi M, et al. Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: a correlative MILD trial study[J]. J Clin Oncol, 2014, 32(8): 768-773.
10 Abbosh C, Birkbak NJ, Wilson GA, et al. Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution[J]. Nature, 2017, 545(7655): 446-451.
11 Hodgkinson CL, Morrow CJ, Li Y, et al. Tumorigenicity and genetic profiling of circulating tumor cells in smallcell lung cancer[J]. Nat Med, 2014, 20(8): 897- 903.
12 Tan EM. Autoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesis[J]. J ClinInvest, 2001, 108(10): 1411-1415.
13 Tan EM, Koziol JA. Autoantibodies in prostate cancer [J]. N Engl J Med, 2005, 353(26): 2815-2817.
14 Kobayashi M, Katayama H, Fahrmann JF, et al. Development of autoantibody signatures for common cancers [J]. Semin Immunol, 2020, 47: 101388.
15 Kolkhir P, Metz M, Altrichter S, et al. Comorbidity of chronic spontaneous urticaria and autoimmune thyroid diseases: A systematic review [J]. Allergy, 2017, 72(10): 1440-1460.
16 Damato V, Balint B, Kienzler AK, et al. The clinical features, underlying immunology, and treatment of autoantibody-mediated movement disorders [J]. Mov Disord, 2018, 33(9): 1376-1389.
17 Chapman CJ, Murray A, McElveen JE, et al. Autoantibodies in lung cancer: possibilities for early detection and subsequent cure[J]. Thorax, 2008, 63(3): 228- 233.
18 Desmetz C, Mange A, Maudelonde T, et al. Autoantibody signatures: progressand perspectives for early cancer detection[J]. J Cell Mol Med, 2011, 15(10): 2013-2024.
19 Chen HD, Werner S, Tao S, et al. Blood autoantibodies against tumor-associatedantigens as biomarkers in early detection of colorectal cancer[J]. Cancer Lett, 2014, 346(2): 178-187.
20 Murray A, Chapman CJ, Healey G, et al. Technical validation of an autoantibody test for lung cancer[J]. Ann Oncol, 2010, 21(8): 1687-1693.
21 Chapman C, Murray A, Chakrabarti J, et al. Autoantibodies in breast cancer: their use as an aid to early diagnosis[J]. Ann Oncol, 2007, 18(5): 868-873.
22 Wu L, Chang W, Zhao J, et al. Development of autoantibody signatures as novel diagnostic biomarkers of non-small cell lung cancer[J]. Clin Cancer Res, 2010, 16(14): 3760-3768.
23 Dail LP, Tsay JC, Li J, et al. Autoantibodies against tumor-associated antigens in the early detection of lung cancer[J]. Lung Cancer, 2016, 99: 172-179.
24 Boyle P, Chapman C, Holdenrieder S, et al. Clinical validation of an autoantibody test for lung cancer[J]. Ann Oncol, 2011, 22(2): 383-389.
25 Sullivan FM, Mair FS, Anderson W, et al. Earlier diagnosis of lung cancer in a randomised trial of an autoantibody blood test followed by imaging[J]. Eur Respir J, 2021, 57(1): 2000670.
26 Ren S, Zhang S, Jiang T, et al. Early detection of lung cancer by using an autoantibody panel in Chinese population[J]. Oncoimmunology, 2017, 7(2): 1384108.
27 Sullivan FM, Farmer E, Mair FS, et al. Detection in blood of autoantibodies totumour antigens as a case-finding method in lung cancer using the EarlyCDT-Lung Test(ECLS): study protocol for a randomized controlled trial[J]. BMC Cancer, 2017, 17(1): 187.
28 Meyer N, Penn LZ. Reflecting on 25 years with MYC[J]. Nat Rev Cancer, 2008, 8(12): 976-990.
29 Panda S, Banerjee N, Chatterjee S. Solute carrier proteins and c-Myc: A strong connection incancer progression[J]. Drug Discov Today, 2020, 25(5): 891-900.
30 Elbadawy M, Usui T, Yamawaki H, et al. Emerging roles of C-Myc in cancer stem cell related signaling and resistance to cancer chemotherapy: A potential therapeutic target against colorectal cancer[J]. Int J Mol Sci, 2019, 20(9): 2340.
31 Li P, Shi JX, Dai LP, et al. Serum anti-MDM2 andanti-c-Myc autoantibodies as biomarkers in the early detection of lung cancer[J]. Oncoimmunology, 2016, 5(5): 1138200.
32 Duan Y, Cui C, Qiu C, et al. Serum Autoantibodies against LRDD, STC1, and FOXA1 as Biomarkers in the Detection of Ovarian Cancer[J]. Dis Markers, 2022, 2022: 6657820.
33 Zhang X, Li J, Wang Y, et al. A Diagnostic Model With IgM Autoantibodies and Carcinoembryonic Antigen for Early Detection of Lung Adenocarcinoma[J]. Front Immunol, 2022, 12: 728853.
34 Li S, Ma Y, Xiong Y, et al. Five tumor-associated autoantibodies expression levels in serum predict lung cancer and associate with poor outcome[J]. Transl Cancer Res, 2019, 8(4): 1364-1373.

备注/Memo

备注/Memo:
通信作者: 金发光, Email: jinfag@fmmu.edu.cn
更新日期/Last Update: 2023-10-20